Replimune Group, Inc.

REPL Healthcare Biotechnology

EPS
+39.7%
Free cash flow
+42.2%
Total debt
+74.3%

Quarter to September 2026, against a year earlier

21.72 1.70 +8.49%
Market cap
$1.9B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Dec '25 Mar '26 Jun '26 Sep '26
Total current assets
280.35 279.12 200.81 324.04
Total non-current assets
53.24 53.27 51.64 49.91
Total Assets
333.59 332.39 252.45 373.94
Total current liabilities
50.09 58.23 38.41 45.55
Total non-current liabilities
72.96 108.00 108.39 123.61
Total liabilities
123.05 166.23 146.80 169.16
Common Equity (Total)
210.54 166.16 105.64 204.78
Shareholders Equity (Total)
210.54 166.16 105.65 204.78
Total Debt
69.76 105.22 105.80 121.22

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 2 Nov 2026